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Samples of uterine leiomyomatis and normal tissues taken from pa-
tients after surgery were investigated using the Positron Annihilation Life-
time Spectroscopy (PALS). Significant differences in all PALS parameters
between normal and diseased tissues were observed. For all studied pa-
tients, it was found that the values of the free annihilation and ortho-
positronium lifetime are larger for the tumorous tissues than for the healthy
ones. For most of the patients, the intensity of the free annihilation and
ortho-positronium annihilation was smaller for the tumorous than for the
healthy tissues. For the first time, in this kind of studies, the 3γ fraction
of positron annihilation was determined to describe changes in the tissue
porosity during morphologic alteration.
DOI:10.5506/APhysPolB.48.1737
1. Introduction
For the last few decades, a positron has become a valuable tool in mate-
rial investigations. Experimental technique based on the positron behaviour
in the medium, Positron Annihilation Lifetime Spectroscopy (PALS), is com-
monly used in investigations of various kind of materials: from metals to
complex mesoporous materials [1–3]. The thermalized positron produced
initially during β decay can directly annihilate with one of the electrons or
create positronium (Ps) i.e. a bound state of a positron and an electron.
Positronium can exist in two different states: para-positronium (p-Ps) and
ortho-positronium (o-Ps), both substates: p-Ps and o-Ps are not stable and
annihilate in the vacuum with a mean lifetime values: 125 ps and 142 ns,
respectively. In the medium however, the o-Ps lifetime value can be short-
ened even below 1 ns due to the possibility of the positronium trapping in
the regions of lower electron density, the so-called free volume or void. In
these voids, o-Ps can annihilate not only by intrinsic decay but with one
of the electrons from its surroundings by pick-off process [4]. Shortening of
the o-Ps lifetime value is determined by the local electron density, which is
correlated with the size of the void where the positronium is trapped [5, 6].
The equation presented below describes the dependence of the o-Ps lifetime
value τpick−off on the void radius R in which positronium is trapped
τpick−off =
1
λb
(
1− R
R+∆
+
1
2pi
sin
(
2piR
R+∆
))−1
, λb = 2 ns
−1 , (1)
where R is the void radius, λb — averaged Ps decay constant, ∆ — empiri-
cal parameter reflecting Ps interaction with the surroundings. The formulas
relating o-Ps lifetime with the void size [7–13] allow to use the o-Ps lifetime
value to determine the void sizes in the range from 0.2 to about 100 nm.
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The o-Ps lifetime in the living organism should be connected to the mor-
phology of the cells and may be used as an indicator of the stage of the
development of metabolic disorders [14].
The other parameter that can be applied to study the porosity of the
material/tissues modification is the fraction fo−Ps−3γ of o-Ps atoms anni-
hilating with the emission of 3γ quanta [15, 16]. Taking into account two
processes leading to o-Ps decay: intrinsic decay and pick-off process, the
3γ fraction can be described as fo−Ps−3γ = τo−Ps/τT , where τT denotes the
o-Ps lifetime value in the vacuum, equal to 142 ns. In the case when only
one kind of free volumes/pores exists in the material, the 3γ fraction in the
whole spectrum can be effectively described by the dependence
f3γ =
(
1− 43Po−Ps
)
372
+
τo−Ps
τT
Po−Ps , (2)
where, Po−Ps denotes the ortho-positronium formation probability depend-
ing on the molecular structure of the investigated object. It was successfully
applied to investigate high-porosity materials [17–20]. In this article, we
describe an application of o-Ps lifetime and intensity as well as the first ap-
plication of the 3γ fraction for investigation of the diseased tissues of human
body.
The PALS was successfully applied in studies of many classes of materi-
als but only in a very limited number of papers concerning living biological
systems. Some applications were described by Jean and Ache in 1977 [21].
They focused on studies of healthy and abnormal skin samples [22, 23] and
reported that the S parameter from the Doppler broadening of annihilation
line is correlated with a broadly defined level of skin damage. For the last
few years, biological systems have aroused the interest of annihilation tech-
niques again [24]. The precise investigations of human tissues seems to be a
very complex problem because of the presence of biofluids where positron-
ium can also undergo annihilation. However, hydrated solid materials were
successfully studied using PALS. In the paper by Hugenschmidt et al. [25],
some experiments concerning the behaviour of the free volume on water
loading, drying, and uniaxial pressure on glucose–gelatine compounds were
performed. The dynamics of the water sorption by hydrophilic lyophilised
yeast cells was studied [26]. The precise understanding of various processes
in biological systems is very important, as they can be applied to increase
the possibilities of human body diagnosis using the Positron Emission To-
mography (PET). One of the innovative scanner (referred to as J-PET) has
been constructed at the Jagiellonian University, Kraków, Poland [27]. One
of the advantages of J-PET is a possibility of multi-photon imaging [28, 29]
which enables the diagnosis based on positron and positronium lifetime [14]
as well as based on the ratio of 3γ and 2γ annihilation rates [15].
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In this paper, the human normal and diseased tissues are investigated
using PALS in order to compare modifications in the tissue structure during
tumour progression.
2. Experimental
2.1. Materials
Uterine leiomyomas are the most common benign uterine tumours in
women. Histologically, they consist mainly of smooth muscle cells and con-
tain different amounts of fibrous tissue. Literature data have shown that
more than 30% of women have myomas [30].
In our study, patients with myomas were qualified to a surgery on the
basis of symptoms, history, clinical examination and ultrasonography. Each
patient underwent hysterectomy with or without adnexa. The study was
approved by the Bioethics Committee of the Medical University of Lublin.
Each patient agreed to a clinical trial. Samples were taken directly from
the organ, just after removal of the uterus from the surgical field by one of
the two experienced researchers in the operating room. Tissue fragments
were taken from the sites rated as macroscopically altered as well as from
the normal tissues and placed directly into a transporting chamber. In
any case, the time of delivery of the tissue to testing, in the same stable
temperature (23± 1◦C) was less than 1 hour. Each of the examined tissues
was subsequently subjected to a histopathological examination (Table I).
2.2. Methods
To perform PALS measurements and compare the results for samples
with tumor and the reference one, two slices of each sample, separated by a
plexiglass partition element, were placed inside the steel chamber presented
in Fig. 1. The total volume of the sample was about 1.5 cm3. The 22Na
positron source with the activity of 700 kBq was placed inside the partition
and inserted between the slices of the sample directly before the measure-
ment. The steel seal assured that the sample was closely attached to the
source. The sample chamber was placed between two scintillation heads,
equipped with BaF2 scintillators, used as START and STOP counters. The
detectors collected the γ quanta corresponding to positron creation inside
the source and positron/positronium annihilation inside the sample, respec-
tively. The electrical impulses from the heads were processed with the use
of standard Fast–Slow delayed coincidence spectrometer [1, 3]. The time
intervals between START and STOP events were measured with the use of
time-to-amplitude converter with the time range of 100 ns. The resolution
curve of the spectrometer was approximated by a single Gaussian with the
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TABLE I
Comparison of the tested samples.
Sample 
number 
Age 
[years] 
Clinical diagnosis 
Macroscopic evaluation 
of the sample 
macroscopically normal 
tissue [N] 
macroscopically altered 
tissue [A] 
Histopathological diagnosis 
 
1 51 Uterine leiomyomas 
N piece of leiomyomatis tissue 
A  piece of leiomyomatis tissue 
2 51 Uterine leiomyomas 
N piece of uterus tissue 
A piece of leiomyomatis tissue 
3 44 Uterine leiomyomas 
N piece of uterus tissue 
A piece of leiomyomatis tissue 
4 43 
Uterine leiomyomas 
Cysts of the ovaries 
N piece of uterus tissue 
A piece of leiomyomatis tissue 
5 39 Uterine leiomyoma 
N piece of uterus tissue 
A piece of leiomyomatis tissue 
6 46 Uterine leiomymas 
N piece of uterus tissue 
A piece of leiomyomatis tissue 
7 46 
Submucosal 
pedunculated fibroid 
N 
fragments of the uterus wall 
tissue  with focal fibrosis 
A 
fragments of leiomyomatis 
tissue with focal fibrosis and 
enamel (glazing?) 
 
 
Fig. 1. Open chamber with tissue sample. The 22Na source was placed in the
hole in the plexiglass plate and then inserted into the sample area (in this case:
left-hand side).
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full width at half maximum (FWHM) of 230 ps. Such parameters allowed to
perform precise measurements of positron/positronium lifetimes from about
100 ps, up to few ns.
In order to exclude the influence of sample aging on PALS results, the ref-
erence sample, and the one with the tumor were measured at the same time,
with the use of two PALS spectrometers of almost identical parameters and
the positron sources of similar activities. After 1.5 hours of measurements,
the samples were swapped, and then, the data from two spectrometers were
compared. The analysis of the results showed that:
— PALS parameters do not depend on the spectrometer;
— In the interval of a few hours, no influence of sample aging on PALS
results was noticed.
The lifetime spectra were analyzed with the use of LT 9.2 program [31]
and three discrete components ascribed to annihilation of para-positronium
(p-Ps, τ1), unbound positrons (e+, τ2) and ortho-positronium (o-Ps, τ3) were
found, respectively, for each sample.
3. Results and discussion
For each patient, a pair of samples was investigated: one normal (N) and
one tumor-altered (A). Exemplary microscopic images for one of the pair of
tissues are presented in Fig. 2. The differences in organization and density
between the healthy and tumorous tissues are well-visible in the micrometer
scale.
Fig. 2. Linear muscle cells of a normal uterus (left) and chaotic fibroid cells (right)
— both images from the tested tissues. Magnification is equal to 100. Figure
length: 0.62 mm and 1.2 mm, respectively.
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The results of PAL spectra analysis for normal (diamond) and altered
(circle) tissues are shown in Fig. 3. For comparison, the reference points for
water (crosses), which is the main constituent of biofluids in living organisms
is added. Water was extensively tested by the PALS technique [32–38], but
for the purpose of this study, additional measurement for deionized water
was carried out under the same measurement conditions as for human tis-
sues. During the LT analyses, all three components were assumed as free. For
human tissues, there are no justified reasons to fix the ratio I1 : I3 = 1 : 3 or
to fix the p-Ps value at 125 ps (it was found that the use of such procedures
significantly modifies the results). This kind of spectra analysis leads to
some parameter misrepresentation, especially the first component intensity
is unviable high, however, it is a justified method in this stage of investi-
gation. Moreover, the main purpose of this paper is a comparison between
normal and altered tissues taken from the same patient and to study the
patient-to-patient variations. From the results presented in Fig. 3, one can
conclude that there are significant differences of results obtained for normal
(and also altered) tissues between different female patients. Therefore, it
is not possible to determine the state of health of the tissue from a single
PAL spectrum measurement, and it is necessary to correlate two measure-
ments performed for normal and altered tissues from the same patient. The
 
(a) (b) (c)
Fig. 3. (Colour on-line) The lifetime and intensity values of PAL spectra compo-
nents for normal (blue diamonds) and altered (red circles) uterine tissue. From
left to right: p-Ps, free annihilation, o-Ps. In addition: uterine leiomyomas tissue
after 16 hours storage in formalin (empty circles) and deionized water at room
temperature (crosses). For the first patient, both samples were classified as altered
by means of the microscopic images.
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differences in the absolute values of the PAL spectra parameters are small
but detectable. While correlating the respective parameters values obtained
for normal and altered tissues from the same patient, a clear trend can be
observed: the lifetime values of all three components in altered tissue are
higher than those measured in normal tissue from the same patient. Similar
relation was observed previously in the literature [22, 39].
The PALS parameters measured in tissues are similar, but not equal,
to those known for water. While the intensity of the components in these
two media are very close, differences are noticeable in the values of all three
lifetimes — in tissues all lifetimes are longer. The greatest discrepancies
were found for the p-Ps lifetime: (0.188 ± 0.006) ns and (0.272 + 0.008) ns
for water and normal tissue sample, respectively.
The comparison of PALS parameters for fresh tissue samples and the
ones conserved in formalin was also performed. The altered tissue from the
second patient after the standard measurement was placed for 16 h in forma-
lin at 23◦C and then measured again with the use of PALS technique. It was
found that the formalin storage significantly influenced the studied param-
eters, especially the o-Ps intensity (an increase from the initial value 19.5%
up to 23% was observed) and the average lifetime of the second component
related to the annihilation of free positrons. Based on the measurement
presented above, it was concluded that samples intended for PALS measure-
ments should not be modified in advance to obtain characteristics for the
possible future in vivo imaging as results should reflect composition of living
organisms.
From data presented in Fig. 3 (a) the void radius (assuming spherical
shape of void) and (b) the fraction of 3γ positron annihilation were calcu-
lated according to equations (1) and (2), respectively (Fig. 4). The differ-
ence in both parameters between the normal and diseased tissues are small
and varies from patient to patient: in the altered tissues, voids are sparingly
larger, while 3γ fraction change non-monotonically. The 3γ fraction depends
on both: lifetime and intensity of o-Ps component which reflect the void size
and the concentration, respectively. In effect, it depends on the porosity
structure of the investigated material. In the case of our measurements, it
may suggest that the observed difference in PALS parameters between nor-
mal and altered tissues reflects the degree or the kind of tissue pathogenic
modification. This conclusion seems to be confirmed by measurements per-
formed on the first sample: the material microscopically considered to be
a normal tissue after the histological examination was qualified as diseased
(Table I); therefore, PALS results reflect the degree of tissue deformation in
one patient (involved with the experimental uncertainty).
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Fig. 4. (Colour on-line) The void radius (left), and 3γ fraction (right), as estimated
from PALS, determined for normal (blue diamonds) and altered (red circles) tissues.
4. Conclusions
The preliminary results of PALS measurements for pairs of samples:
normal and diseased, taken from patients’ uterus just after surgery and
not solidified show small but meaningful differences inside the pair and be-
tween the patients. For all studied patients, the free annihilation and ortho-
positronium lifetime values were found to be larger for the diseased tissues
with respect to the lifetime of the normal ones. At the same time, the in-
tensity of both components, generally, was found to be smaller for altered
tissues than for the normal ones. Our results that provide the information
on the molecular scale of the tissues structure justify the expectation that
PALS measurements of positron and positronium parameters could be useful
in the cancer/tumour diagnostics. They constitute the first step on a way to
establish correlations between positronium properties in the tissue and the
staging of tumours for the elaboration of the in vivo morphometric imaging
proposed in [14, 15].
However, to unequivocally conclude the existence of such correlations, a
large number of patients and different kinds of tumours/cancers have to be
analyzed.
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